“…This concept is accepted in some countries, including the Netherlands and the UK, where moderate hypofractionation has been the standard for practically all indications of RT in breast-cancer patients for many years [ 35 , 39 , 40 ]. The results of prospectively collected databases and other real-life retrospective studies confirm that hypofractionated RT, with or without regional nodal irradiation, is safe, well-tolerated, and associated with satisfactory local control rates [ [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] ].…”